Cyclo Therapeutics Inc (CTDH):企業の財務・戦略的SWOT分析

◆英語タイトル:Cyclo Therapeutics Inc (CTDH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH207630FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cyclo Therapeutics Inc (Cyclo Therapeutics), formerly CTD Holdings Inc, is a biotechnology company that develops and manufactures cyclodextrin-based drugs. It is investigating Trappsol Cyclo, an orphan drug against Niemann-Pick disease type C and Alzheimer’s disease. The company also develops antibiotics, antiulcerants, throat disinfectants, vasodilators, antifungal drugs and other medications to treat chronic arterial occlusive disease, Buerger’s disease; control hypo-tension during surgery; and induction of labor. It serves diagnostics, industrial chemical industries, pharmaceutical and chemical supply distributors. Cyclo Therapeutics is headquartered in Alachua, Florida, the US.

Cyclo Therapeutics Inc Key Recent Developments

Mar 25,2021: Cyclo Therapeutics Meets Primary Efficacy Endpoint in Phase 1/2 Trial from Intravenous Trappsol® Cyclo™ in Rare Disease Niemann-Pick Type C1 (NPC1)
Mar 15,2021: Cyclo Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Mar 10,2021: Cyclo Therapeutics Appoints Russ Belden as Acting Chief Commercial Officer
Mar 01,2021: Cyclo Therapeutics Appoints Gerald F. Cox, MD, PhD as Acting Chief Medical Officer

This comprehensive SWOT profile of Cyclo Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cyclo Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cyclo Therapeutics Inc – Key Information
Cyclo Therapeutics Inc – Overview
Cyclo Therapeutics Inc – Key Employees
Cyclo Therapeutics Inc – Key Employee Biographies
Cyclo Therapeutics Inc – Key Operational Heads
Cyclo Therapeutics Inc – Major Products and Services
Cyclo Therapeutics Inc – History
Cyclo Therapeutics Inc – Company Statement
Cyclo Therapeutics Inc – Locations And Subsidiaries
Cyclo Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cyclo Therapeutics Inc – Business Description
Cyclo Therapeutics Inc – Corporate Strategy
Cyclo Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Cyclo Therapeutics Inc – Strengths
Cyclo Therapeutics Inc – Weaknesses
Cyclo Therapeutics Inc – Opportunities
Cyclo Therapeutics Inc – Threats
Cyclo Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Cyclo Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cyclo Therapeutics Inc, Key Information
Cyclo Therapeutics Inc, Key Ratios
Cyclo Therapeutics Inc, Share Data
Cyclo Therapeutics Inc, Major Products and Services
Cyclo Therapeutics Inc, History
Cyclo Therapeutics Inc, Key Employees
Cyclo Therapeutics Inc, Key Employee Biographies
Cyclo Therapeutics Inc, Key Operational Heads
Cyclo Therapeutics Inc, Other Locations
Cyclo Therapeutics Inc, Subsidiaries
Cyclo Therapeutics Inc, Key Competitors
Cyclo Therapeutics Inc, SWOT Analysis
Cyclo Therapeutics Inc, Ratios based on current share price
Cyclo Therapeutics Inc, Annual Ratios
Cyclo Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cyclo Therapeutics Inc (CTDH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IV Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary IV Diagnostics Inc (IV Diagnostics) is a biomedical company that offers research services. The company conducts molecular diagnostic tests for circulating tumor cells and other blood borne diseases. It develops, tests and markets diagnostic tools that monitor and measure cancer tumor cells. …
  • Applied Genetic Technologies Corp (AGTC):企業の財務・戦略的SWOT分析
    Summary Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. AGTC offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis …
  • Vossloh AG:企業のM&A・事業提携・投資動向
    Vossloh AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vossloh AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • American Woodmark Corp (AMWD):企業の財務・戦略的SWOT分析
    American Woodmark Corp (AMWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Alberta Investment Management Corporation:企業の戦略・SWOT・財務情報
    Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report Summary Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Carillion plc:戦略・SWOT・企業財務分析
    Carillion plc - Strategy, SWOT and Corporate Finance Report Summary Carillion plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Zoll Medical Corporation:企業の戦略的SWOT分析
    Zoll Medical Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Copenhagen Infrastructure Partners KS:電力:M&Aディール及び事業提携情報
    Summary Copenhagen Infrastructure Partners KS (CIP) is a fund management service provider. The company provides structuring, executing and managing investments within energy infrastructure. It invests in energy infrastructure assets including offshore wind, onshore wind, offshore power transmission, …
  • AIB Group Plc:企業の戦略・SWOT・財務情報
    AIB Group Plc - Strategy, SWOT and Corporate Finance Report Summary AIB Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Husqvarna AB (HUSQ B):企業の財務・戦略的SWOT分析
    Summary Husqvarna AB (Husqvarna) is an industrial equipment company. The company produces outdoor power products for forestry, gardening and construction. It offers wheeled products, electric products. Husqvarna also provides handheld products, watering and hand tools, accessories, and construction …
  • Adpo Group NV:企業の戦略的SWOT分析
    Adpo Group NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Hotel Excelsior d.d.:企業の戦略・SWOT・財務分析
    Hotel Excelsior d.d. - Strategy, SWOT and Corporate Finance Report Summary Hotel Excelsior d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • American Electric Power Company, Inc. (AEP)-エネルギー分野:企業M&A・提携分析
    Summary American Electric Power Company, Inc. (AEP) is a holding company that carries out the generation, transmission and distribution of electricity through its subsidiaries. The company generates electricity through various sources of energy such as coal and lignite, natural gas, nuclear, and hyd …
  • Jordan Health Services Inc-製薬・医療分野:企業M&A・提携分析
    Summary Jordan Health Services Inc (Jordan) is a healthcare service provider that offers home healthcare services. The center offers personal care services, home management, pediatric services, skilled care and hospice services. It provides pediatric programs which include comprehensive care program …
  • Exillon Energy Plc (EXI):企業の財務・戦略的SWOT分析
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • Hebei Construction Group Co Ltd (1727):企業の財務・戦略的SWOT分析
    Hebei Construction Group Co Ltd (1727) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Al Hassan Engineering Co (HECI):企業の財務・戦略的SWOT分析
    Al Hassan Engineering Co (HECI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Advanced Marker Discovery SL-医療機器分野:企業M&A・提携分析
    Summary Advanced Marker Discovery SL (Amadix) is a developer and discoverer of cancer diagnostic products. The company offers test products and diagnostic tools for lung cancer, colon cancer and prostate cancer. It provides diagnostic tools that support the physician’s decisions about patient manage …
  • ManTech International Corporation (MANT):企業の財務・戦略的SWOT分析
    ManTech International Corporation (MANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Medicamen Biotech Ltd (531146):企業の財務・戦略的SWOT分析
    Medicamen Biotech Ltd (531146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆